Drug intelligence / Profile preview

Tepilta

Development stage
Discontinued
Lead developer
MEDA Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Tepilta is an oral suspension fixed-combination product containing the local anesthetic oxetacaine (oxethazaine) and antacids (aluminum hydroxide plus magnesium hydroxide), developed to treat pain and inflammation of the esophagus, particularly radiation-induced esophagitis.[7][11] Oxetacaine is a potent, long-acting topical anesthetic that blocks voltage-gated sodium channels in peripheral sensory nerves in the upper gastrointestinal tract, thereby reducing pain perception, while the antacid components neutralize gastric acid and provide mucosal protection.[5][7][11] The product has been evaluated in a double-blind randomized clinical trial to demonstrate superior efficacy of the combination versus its individual components and placebo in patients with radiation-induced esophagitis.[7][11]

Brand names
Tepilta
02

Targets

HCl (Hydrochloric acid)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on Tepilta.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tepilta.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call